Orion Capital Management’s Editas Medicine EDIT Stock Holding History

Orion Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$348	–	479
2025 Q1	$348	Hold	300	–	–	﹤0.01%	464
2024 Q4	$381	Buy	+300	New	+$764	﹤0.01%	472
2024 Q3	–	Sell	-300	Closed	-$1.4K	–	244
2024 Q2	$1.4K	Sell	300 -1,000	-77%	-$5.64K	﹤0.01%	414
2024 Q1	$9.65K	Hold	1,300	–	–	0.01%	378
2023 Q4	$13.2K	Hold	1,300	–	–	0.01%	369
2023 Q3	$10.1K	Buy	+1,300	New	+$11.1K	0.01%	382
2023 Q2	–	Sell	-3,750	Closed	-$27.2K	–	235
2023 Q1	$27.2K	Sell	3,750 -300	-7%	-$2.67K	0.02%	286
2022 Q4	$35.9K	Sell	4,050 -600	-13%	-$6.59K	0.03%	224
2022 Q3	$57K	Hold	4,650	–	–	0.05%	187
2022 Q2	$55K	Sell	4,650 -800	-15%	-$10.7K	0.04%	186
2022 Q1	$104K	Hold	5,450	–	–	0.06%	165
2021 Q4	$145K	Buy	+5,450	New	+$188K	0.08%	141

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Orion Capital Management's EDIT Position: Q2 2025 in Review

Orion Capital Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 300 shares — an estimated $348 sold.

Orion Capital Management first reported a position in EDIT in Q4 2021 and held it in 12 quarters. The position peaked at $145K in Q4 2021. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

Orion Capital Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
Orion Capital Management sold 300 Editas Medicine shares in Q2 2025, an estimated $348.
Orion Capital Management first reported a position in Editas Medicine in Q4 2021 and held it in 12 quarters.
Orion Capital Management's Editas Medicine position peaked at $145K in Q4 2021.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Orion Capital Management's 13F filing for Q2 2025, filed 31 Jul 2025.